STOCK TITAN

LeMaitre to Participate at Upcoming Investor Conferences in September

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

LeMaitre Vascular (Nasdaq: LMAT) has announced its participation in three major investor conferences this September. The company's management will be presenting at:

  • The Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, in New York, with President David Roberts presenting at 5:35 PM EST.
  • The Barrington Research Fall Investment Conference (Virtual) on September 12, 2024, where Chairman & CEO George W. LeMaitre will host one-on-one meetings.
  • The Cantor Fitzgerald 2024 Global Healthcare Conference on September 19, 2024, in New York, with David Roberts presenting at 8:00 AM EST.

These conferences provide LeMaitre Vascular with opportunities to engage with investors and showcase their business strategies and performance.

LeMaitre Vascular (Nasdaq: LMAT) ha annunciato la sua partecipazione a tre importanti conferenze per investitori questo settembre. La gestione dell'azienda presenterà a:

  • La 22ª Conferenza Globale sulla Sanità Annuale di Morgan Stanley il 4 settembre 2024 a New York, con il Presidente David Roberts che presenterà alle 17:35 EST.
  • La Conferenza di Investimento Autunnale di Barrington Research (Virtuale) il 12 settembre 2024, dove il Presidente e CEO George W. LeMaitre ospiterà incontri individuali.
  • La Conferenza Globale sulla Sanità 2024 di Cantor Fitzgerald il 19 settembre 2024 a New York, con David Roberts che presenterà alle 8:00 EST.

Queste conferenze offrono a LeMaitre Vascular opportunità per interagire con gli investitori e presentare le loro strategie aziendali e i risultati.

LeMaitre Vascular (Nasdaq: LMAT) ha anunciado su participación en tres importantes conferencias de inversores este septiembre. La administración de la empresa presentará en:

  • La 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre de 2024 en Nueva York, con el presidente David Roberts presentando a las 5:35 PM EST.
  • La Conferencia de Inversión de Otoño de Barrington Research (Virtual) el 12 de septiembre de 2024, donde el presidente y CEO George W. LeMaitre llevará a cabo reuniones uno a uno.
  • La Conferencia Global de Salud 2024 de Cantor Fitzgerald el 19 de septiembre de 2024 en Nueva York, con David Roberts presentando a las 8:00 AM EST.

Estas conferencias brindan a LeMaitre Vascular oportunidades para interactuar con inversores y mostrar sus estrategias empresariales y desempeño.

LeMaitre Vascular (Nasdaq: LMAT)는 이번 9월에 세 가지 주요 투자자 회의에 참여한다고 발표했습니다. 회사 경영진은 다음의 회의에서 발표할 예정입니다:

  • 뉴욕에서 2024년 9월 4일에 열리는 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스, 오전 5시 35분 EST에 회장 데이비드 로버츠가 발표합니다.
  • 2024년 9월 12일에 열리는 배링턴 리서치 가을 투자 컨퍼런스 (온라인)에서는 회장 겸 CEO인 조지 W. 르메이르가 일대일 미팅을 진행합니다.
  • 뉴욕에서 2024년 9월 19일에 열리는 칸토르 피츠제럴드 2024 글로벌 헬스케어 컨퍼런스에서 데이비드 로버츠가 오전 8시 EST에 발표할 예정입니다.

이 회의들은 LeMaitre Vascular에게 투자자와 소통하고 비즈니스 전략 및 성과를 보여줄 기회를 제공합니다.

LeMaitre Vascular (Nasdaq: LMAT) a annoncé sa participation à trois importantes conférences pour investisseurs ce septembre. La direction de l'entreprise présentera à :

  • La 22ème Conférence Annuelle Mondiale de la Santé de Morgan Stanley le 4 septembre 2024 à New York, avec le Président David Roberts présentant à 17h35 EST.
  • La Conférence d'Investissement Automnale de Barrington Research (virtuelle) le 12 septembre 2024, où le Président et CEO George W. LeMaitre animera des réunions individuelles.
  • La Conférence Mondiale de la Santé 2024 de Cantor Fitzgerald le 19 septembre 2024 à New York, avec David Roberts présentant à 8h00 EST.

Ces conférences offrent à LeMaitre Vascular des opportunités d'interagir avec les investisseurs et de présenter leurs stratégies commerciales et performances.

LeMaitre Vascular (Nasdaq: LMAT) hat seine Teilnahme an drei wichtigen Investorenkonferenzen im September bekannt gegeben. Das Management des Unternehmens wird bei folgenden Konferenzen präsentieren:

  • Der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley am 4. September 2024 in New York, wobei Präsident David Roberts um 17:35 Uhr EST präsentieren wird.
  • Der Herbst-Investorenkonferenz von Barrington Research (virtuell) am 12. September 2024, bei der der Vorsitzende und CEO George W. LeMaitre persönliche Gespräche führen wird.
  • Der Cantor Fitzgerald 2024 Global Healthcare Conference am 19. September 2024 in New York, mit David Roberts, der um 8:00 Uhr EST präsent sein wird.

Diese Konferenzen bieten LeMaitre Vascular die Möglichkeit, mit Investoren in Kontakt zu treten und ihre Geschäftsstrategien und -leistungen vorzustellen.

Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.

Morgan Stanley 22nd Annual Global Healthcare Conference
Wednesday, September 4, 2024
New York Marriott Marquis, New York, NY
David Roberts, President, will present at 5:35 PM EST

Barrington Research Fall Investment Conference (Virtual)
Thursday, September 12, 2024
George W. LeMaitre, Chairman & CEO, is scheduled to host a series of 1x1 meetings

Cantor Fitzgerald 2024 Global Healthcare Conference
Thursday, September 19, 2024
InterContinental New York Barclay Hotel, New York, NY
David Roberts, President, will present at 8:00 AM EST

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.


FAQ

What investor conferences will LeMaitre Vascular (LMAT) attend in September 2024?

LeMaitre Vascular (LMAT) will attend three investor conferences in September 2024: Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, Barrington Research Fall Investment Conference on September 12, and Cantor Fitzgerald 2024 Global Healthcare Conference on September 19.

Who will represent LeMaitre Vascular (LMAT) at the Morgan Stanley Healthcare Conference in September 2024?

David Roberts, President of LeMaitre Vascular (LMAT), will represent the company and present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 5:35 PM EST.

When and where will LeMaitre Vascular (LMAT) present at the Cantor Fitzgerald Global Healthcare Conference in 2024?

LeMaitre Vascular (LMAT) will present at the Cantor Fitzgerald 2024 Global Healthcare Conference on Thursday, September 19, 2024, at 8:00 AM EST. The conference will be held at the InterContinental New York Barclay Hotel in New York, NY.

What is the format of LeMaitre Vascular's (LMAT) participation in the Barrington Research Fall Investment Conference 2024?

At the Barrington Research Fall Investment Conference on September 12, 2024, which is a virtual event, George W. LeMaitre, Chairman & CEO of LeMaitre Vascular (LMAT), is scheduled to host a series of one-on-one meetings with investors.

LeMaitre Vascular, Inc.

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Stock Data

2.41B
20.50M
8.84%
94.18%
3.49%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
BURLINGTON